arrow
R

Rafał Suwiński

Maria Sklodowska-Curie National Research Institute of Oncology
H指数:25
被引数:3,193

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of efficacy and toxicity of dabrafenib/ trametinib versus vemurafenib/cobimetinib therapy in routine medical practice: Eight years of BRAF/MEK inhibitor use in routine clinical practice
2023-10-011
PRE
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients
2023-06-013
PRE
Immunotherapy with radiotherapy fails to improve prognosis of patients with stage IV non-small cell lung cancer: a retrospective cohort analysis of the THUNDER-2 study

放疗联合免疫治疗未能改善IV期非小细胞肺癌患者的预后: 一项对thander-2研究的回顾性队列分析

2022-12-012
OAAI
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy
2022-10-083
OAAI
International consensus on radiotherapy in metastatic non-small cell lung cancer

转移性非小细胞肺癌放疗的国际共识

2022-09-0117
OAAI
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence

BRAF突变的晚期皮肤黑色素瘤患者一线免疫治疗后靶向治疗的长期结果-现实世界证据

2022-04-175
OAAI